Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,849 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06032975 | PRO for Fighting FT in Ovarian Cancer(MITO45-ProFFiT) | recruiting | — | 240 | National Cancer Institute, NaplesOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06010875 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 48 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Nov 8, 2023 |
| clinicaltrials |
| NCT06116396 | Liquid Biospy for Urinary Cancers(CIRCE) | recruiting | — | 450 | IRCCS San RaffaeleOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06117384 | Systems Oncology Approach to Optimize Ovarian Cancer Treatment(ONCOSYS-OVA) | recruiting | — | 500 | University of HelsinkiOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06118307 | Shanghai Ovarian Cancer and Family Care Project | recruiting | — | 3,546 | Shanghai First Maternity and Infant HospitalOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06116019 | Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)(ART-02) | recruiting | — | 649 | Charite University, Berlin, GermanyOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06116851 | Prostate Metabolism, Cancer Risk and Gut Microbiota(PROMIC) | recruiting | — | 300 | Turku University HospitalOTHER_GOV | 1 | Nov 3, 2023 | clinicaltrials |
| NCT06103916 | Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice(PRIORITY) | recruiting | — | 613 | Maxima Medical CenterOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT03034187 | Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate(SFP-PROSTATE) | recruiting | — | 10,000 | University Medical Center GroningenOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05406856 | PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer(PROTECT) | recruiting | N/A | 30 | Leiden University Medical CenterOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT05749887 | The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer. | recruiting | N/A | 188 | Chongqing University Cancer HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT03216525 | Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol | recruiting | Phase 3 | 136 | Brigham and Women's HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06055738 | Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC | recruiting | Phase 2 | 20 | Tang-Du HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05832736 | Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer(RETURN) | recruiting | N/A | 36 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Sep 26, 2023 | clinicaltrials |
| NCT04549688 | Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer | recruiting | N/A | 250 | The Hospital of VestfoldOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT03379909 | Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer(TROJAN) | recruiting | Phase 2 | 49 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06028724 | A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)(POPCORN) | recruiting | — | 782 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05405270 | Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment(PRedICT-TOPIC) | recruiting | — | 410 | Catharina Ziekenhuis EindhovenOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT05511623 | Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer | recruiting | Phase 2 | 112 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT05600127 | Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer(CHASIT) | recruiting | Phase 2 | 64 | Erasmus Medical CenterOTHER | 1 | Sep 8, 2023 | clinicaltrials |
| NCT04989647 | Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy(CERVANTES) | recruiting | Phase 3 | 514 | The Central and Eastern European Gynecologic Oncology GroupOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT06026189 | Safely Reduce Cystoscopic Evaluations for Hematuria Patients(SeARCH) | recruiting | N/A | 1,100 | Erasmus Medical CenterOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05378087 | Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer | recruiting | N/A | 1,956 | Chongqing University Cancer HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT06001619 | Prostate Medication, Metabolism and Gut Microbiota(PROMED) | recruiting | Phase 4 | 100 | Turku University HospitalOTHER_GOV | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05983783 | Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC | recruiting | Phase 3 | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05076942 | Groningen International Study on Sentinel Nodes in Vulvar Cancer-III(GROINSS-VIII) | recruiting | Phase 2 | 157 | University Medical Center GroningenOTHER | 2 | Aug 1, 2023 | clinicaltrials |
| NCT05709769 | Radiomics-based Malnutrition for Cervical Cancer. | recruiting | — | 150 | Zhejiang Provincial People's HospitalOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05937958 | MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)(MARGARITA) | recruiting | — | 30 | UMC UtrechtOTHER | 2 | Jul 18, 2023 | clinicaltrials |
| NCT05950087 | Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy | recruiting | — | 30 | Guizhou Provincial People's HospitalOTHER | 1 | Jul 18, 2023 | clinicaltrials |
| NCT05945407 | Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer | recruiting | N/A | 57 | Peking University People's HospitalOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05943379 | RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects | recruiting | Phase 2 | 85 | RemeGen Co., Ltd.INDUSTRY | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05833321 | Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer(SARCO-GYN) | recruiting | N/A | 75 | Centre Hospitalier Metropole SavoieOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04654338 | 2 Ablative RadioTherapy Treatments for Prostate Cancer(EARTH) | recruiting | Phase 2 / Phase 3 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT05431530 | Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer(LAPSODY) | recruiting | — | 108 | Seoul National University HospitalOTHER | 1 | Jun 27, 2023 | clinicaltrials |
| NCT04370496 | Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION)(SOLUTION) | recruiting | N/A | 124 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05753839 | The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial(SEVURO-CN) | recruiting | N/A | 40 | Yonsei UniversityOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05912972 | Development and Management of Registry in Patients With Gynecologic Cancer in Korea | recruiting | — | 13,500 | Asan Medical CenterOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT04519151 | Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer | recruiting | Phase 2 | 24 | Sheba Medical CenterOTHER_GOV | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05884632 | Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients(DART-PHASER) | recruiting | N/A | 184 | IRCCS Sacro Cuore Don Calabria di NegrarOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT04617756 | Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract(iNDUCT) | recruiting | Phase 2 | 50 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05606692 | Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)(anesthetics) | recruiting | Phase 4 | 416 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05872724 | Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) | recruiting | Phase 2 | 32 | Suzhou Municipal HospitalOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT05209243 | START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC(START-MET) | recruiting | N/A | 266 | Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología RadioterápicOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05251883 | A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics | recruiting | — | 200 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05862740 | ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer(ULTRA-LAP) | recruiting | N/A | 62 | Azienda Ospedaliera di PadovaOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT04583254 | Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study | recruiting | Phase 2 | 48 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05817903 | Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients(AxIn) | recruiting | Phase 2 | 118 | Consorzio OncotechOTHER | 1 | May 8, 2023 | clinicaltrials |
| NCT05840575 | Investigating Cognitive Impairment in Young Patients With Cancer Prospectively(MyBrain) | recruiting | — | 100 | Rigshospitalet, DenmarkOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT03275194 | HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy | recruiting | Phase 2 | 100 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT02429687 | TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors(MOGCT-01) | recruiting | Phase 3 | 129 | Beihua KongOTHER | 1 | Apr 25, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Nov 13, 2023source: clinicaltrials